Azenta Stock
Azenta, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- United States
- CEO
- Martin D. Madaus
- Employees
- 2,900
- Market cap
- $1.5 B
- IPO
- 02/02/1995
Azenta, Inc. is a global leader in the healthcare sector, specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company is headquartered in Burlington, US, and operates across North America, Europe, Asia Pacific including China, and other international markets.…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Azenta stock: price history
1D
-6.7%
1W
-9.6%
1M
+2.6%
6M
+36.1%
YTD
+2.5%
1Y
+8.2%
2Y
-22.5%
5Y
-67.0%
10Y
+156.3%
Next earnings date
Next earnings date
20/11/2026 (in 34 days)
Volatility around earnings
~100% stronger price swings than usual
Ask the agents about Azenta
Analyst assessment of Azenta
PRICE TARGET LOW
US$38.00
CONSENSUS
US$43.00
MEDIAN
US$44.50
PRICE TARGET HIGH
US$45.00
0
STRONG BUY
7
BUY
5
HOLD
0
SELL
0
STRONG SELL
12
TOTAL · Buy
As of: 14/09/2026
Azenta stock metrics
P/E
-12.4
P/B
1.02
EV/EBITDA
-14.06
RETURN ON EQUITY
0.2%
NET MARGIN
1.5%
DEBT/EQUITY
0.04
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
88.7%
FLOAT SHARES
38,876,882
AVG. DAILY VOLUME (30D)
1,137,266
Insider transactions (SEC)
Madaus Martin D
Bello Erik J.
Starr Ephraim
Lin Lawrence Y.
Pirogova Olga
Institutional holders
Dividends
Comparable stocks
Frequently asked questions about Azenta stock
What does Azenta do?
Azenta, Inc. is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is Martin D. Madaus, the company employs around 2,900 people.
The IPO was on 02/02/1995; the stock trades on NASDAQ under the ticker AZTA.
What do analysts say about Azenta stock?
12 analysts rate the stock, the consensus is Buy (as of 14/09/2026).
The average price target is US$43.00, ranging from US$38.00 to US$45.00, with a median of US$44.50.
This is an external assessment, not a statement by Market Jury.
When does Azenta report next?
The next earnings date is 20/11/2026.
Around past earnings, price swings were roughly 100% stronger than usual.
Does Azenta pay a dividend?
Yes. The last dividend was US$0.10 per share, ex-date 02/12/2021, paid on 23/12/2021.
The dividend yield is 0.0% (as of 30/06/2026).
Which stocks are comparable to Azenta?
Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum, Baxter International, Cooper Companies and Avantor.
How can I get Azenta stock analyzed?
Clicking "Analyze stock" lets five strategies assess Azenta against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.